These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 32541897)

  • 41. Targeted Protein Degradation by Small Molecules.
    Bondeson DP; Crews CM
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():107-123. PubMed ID: 27732798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction.
    Simonetta KR; Taygerly J; Boyle K; Basham SE; Padovani C; Lou Y; Cummins TJ; Yung SL; von Soly SK; Kayser F; Kuriyan J; Rape M; Cardozo M; Gallop MA; Bence NF; Barsanti PA; Saha A
    Nat Commun; 2019 Mar; 10(1):1402. PubMed ID: 30926793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Covalent fragment libraries in drug discovery.
    Keeley A; Petri L; Ábrányi-Balogh P; Keserű GM
    Drug Discov Today; 2020 Jun; 25(6):983-996. PubMed ID: 32298798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and characterization of cancer vulnerabilities via targeted protein degradation.
    Mayor-Ruiz C; Winter GE
    Drug Discov Today Technol; 2019 Apr; 31():81-90. PubMed ID: 31200863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of Selective Small Molecule Degraders of BRAF-V600E.
    Han XR; Chen L; Wei Y; Yu W; Chen Y; Zhang C; Jiao B; Shi T; Sun L; Zhang C; Xu Y; Lee MR; Luo Y; Plewe MB; Wang J
    J Med Chem; 2020 Apr; 63(8):4069-4080. PubMed ID: 32223235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Tale of Two Tails: Efficient Profiling of Protein Degraders by Specific Functional and Target Engagement Readouts.
    Chernobrovkin AL; Cázares-Körner C; Friman T; Caballero IM; Amadio D; Martinez Molina D
    SLAS Discov; 2021 Apr; 26(4):534-546. PubMed ID: 33445986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery.
    Pei J; Wang G; Feng L; Zhang J; Jiang T; Sun Q; Ouyang L
    J Med Chem; 2021 Apr; 64(7):3493-3507. PubMed ID: 33764774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Target Validation Using PROTACs: Applying the Four Pillars Framework.
    Nowak RP; Jones LH
    SLAS Discov; 2021 Apr; 26(4):474-483. PubMed ID: 33334221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of reversible and irreversible covalent chemistry in targeted protein degradation.
    Kiely-Collins H; Winter GE; Bernardes GJL
    Cell Chem Biol; 2021 Jul; 28(7):952-968. PubMed ID: 33789091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The discovery of potent small molecule activators of human STING.
    Pryde DC; Middya S; Banerjee M; Shrivastava R; Basu S; Ghosh R; Yadav DB; Surya A
    Eur J Med Chem; 2021 Jan; 209():112869. PubMed ID: 33038794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fundamental aspects of DMPK optimization of targeted protein degraders.
    Cantrill C; Chaturvedi P; Rynn C; Petrig Schaffland J; Walter I; Wittwer MB
    Drug Discov Today; 2020 Jun; 25(6):969-982. PubMed ID: 32298797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted protein degraders crowd into the clinic.
    Mullard A
    Nat Rev Drug Discov; 2021 Apr; 20(4):247-250. PubMed ID: 33737725
    [No Abstract]   [Full Text] [Related]  

  • 53. Effective degradation of EGFR
    Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B
    Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. From Inhibition to Degradation: Targeting the Antiapoptotic Protein Myeloid Cell Leukemia 1 (MCL1).
    Papatzimas JW; Gorobets E; Maity R; Muniyat MI; MacCallum JL; Neri P; Bahlis NJ; Derksen DJ
    J Med Chem; 2019 Jun; 62(11):5522-5540. PubMed ID: 31117518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs).
    Tomaselli D; Mautone N; Mai A; Rotili D
    Eur J Med Chem; 2020 Dec; 207():112750. PubMed ID: 32871345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemical Biology Probes from Advanced DNA-encoded Libraries.
    Salamon H; Klika Škopić M; Jung K; Bugain O; Brunschweiger A
    ACS Chem Biol; 2016 Feb; 11(2):296-307. PubMed ID: 26820267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective targeting of non-centrosomal AURKA functions through use of a targeted protein degradation tool.
    Wang R; Ascanelli C; Abdelbaki A; Fung A; Rasmusson T; Michaelides I; Roberts K; Lindon C
    Commun Biol; 2021 May; 4(1):640. PubMed ID: 34050235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small-molecule degraders of cyclin-dependent kinase protein: a review.
    Yu B; Du Z; Zhang Y; Li Z; Bian J
    Future Med Chem; 2022 Jan; 14(3):167-185. PubMed ID: 34939427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PROTACs to address the challenges facing small molecule inhibitors.
    Martín-Acosta P; Xiao X
    Eur J Med Chem; 2021 Jan; 210():112993. PubMed ID: 33189436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.
    Ward CC; Kleinman JI; Brittain SM; Lee PS; Chung CYS; Kim K; Petri Y; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Nomura DK
    ACS Chem Biol; 2019 Nov; 14(11):2430-2440. PubMed ID: 31059647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.